Literature DB >> 35356988

A point mutation in human coilin prevents Cajal body formation.

Davide A Basello1,2, A Gregory Matera3, David Staněk1.   

Abstract

Coilin is a conserved protein essential for integrity of nuclear membrane-less inclusions called Cajal bodies. Here, we report an amino acid substitution (p.K496E) found in a widely-used human EGFP-coilin construct that has a dominant-negative effect on Cajal body formation. We show that this coilin-K496E variant fails to rescue Cajal bodies in cells lacking endogenous coilin, whereas the wild-type construct restores Cajal bodies in mouse and human coilin-knockout cells. In cells containing endogenous coilin, both the wild-type and K496E variant proteins accumulate in Cajal bodies. However, high-level overexpression of coilin-K496E causes Cajal body disintegration. Thus, a mutation in the C-terminal region of human coilin can disrupt Cajal body assembly. Caution should be used when interpreting data from coilin plasmids that are derived from this variant (currently deposited at Addgene).
© 2022. Published by The Company of Biologists Ltd.

Entities:  

Keywords:  Cajal bodies; Coilin; Mutation

Mesh:

Substances:

Year:  2022        PMID: 35356988      PMCID: PMC9080554          DOI: 10.1242/jcs.259587

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.235


  37 in total

1.  Inhibition of protein dephosphorylation results in the accumulation of splicing snRNPs and coiled bodies within the nucleolus.

Authors:  C E Lyon; K Bohmann; J Sleeman; A I Lamond
Journal:  Exp Cell Res       Date:  1997-01-10       Impact factor: 3.905

2.  UbiSite approach for comprehensive mapping of lysine and N-terminal ubiquitination sites.

Authors:  Vyacheslav Akimov; Inigo Barrio-Hernandez; Sten V F Hansen; Philip Hallenborg; Anna-Kathrine Pedersen; Dorte B Bekker-Jensen; Michele Puglia; Stine D K Christensen; Jens T Vanselow; Mogens M Nielsen; Irina Kratchmarova; Christian D Kelstrup; Jesper V Olsen; Blagoy Blagoev
Journal:  Nat Struct Mol Biol       Date:  2018-07-02       Impact factor: 15.369

3.  Structure and characterization of the murine p80 coilin gene, Coil.

Authors:  K E Tucker; L K Massello; L Gao; T J Barber; M D Hebert; E K Chan; A G Matera
Journal:  J Struct Biol       Date:  2000-04       Impact factor: 2.867

4.  The C-terminal domain of coilin interacts with Sm proteins and U snRNPs.

Authors:  Hongzhi Xu; Ramesh S Pillai; Teldja N Azzouz; Karl B Shpargel; Christian Kambach; Michael D Hebert; Daniel Schümperli; A Gregory Matera
Journal:  Chromosoma       Date:  2005-07-08       Impact factor: 4.316

5.  Coilin phosphorylation mediates interaction with SMN and SmB'.

Authors:  Cory G Toyota; Misty D Davis; Angela M Cosman; Michael D Hebert
Journal:  Chromosoma       Date:  2009-12-08       Impact factor: 4.316

6.  Dynamic interactions between splicing snRNPs, coiled bodies and nucleoli revealed using snRNP protein fusions to the green fluorescent protein.

Authors:  J Sleeman; C E Lyon; M Platani; J P Kreivi; A I Lamond
Journal:  Exp Cell Res       Date:  1998-09-15       Impact factor: 3.905

7.  Cell cycle-dependent localization of the CDK2-cyclin E complex in Cajal (coiled) bodies.

Authors:  J Liu; M D Hebert; Y Ye; D J Templeton; H Kung; A G Matera
Journal:  J Cell Sci       Date:  2000-05       Impact factor: 5.285

8.  Human autoantibody to a novel protein of the nuclear coiled body: immunological characterization and cDNA cloning of p80-coilin.

Authors:  L E Andrade; E K Chan; I Raska; C L Peebles; G Roos; E M Tan
Journal:  J Exp Med       Date:  1991-06-01       Impact factor: 14.307

9.  Assembly of snRNP-containing coiled bodies is regulated in interphase and mitosis--evidence that the coiled body is a kinetic nuclear structure.

Authors:  M Carmo-Fonseca; J Ferreira; A I Lamond
Journal:  J Cell Biol       Date:  1993-02       Impact factor: 10.539

10.  Identification and characterization of a sphere organelle protein.

Authors:  R S Tuma; J A Stolk; M B Roth
Journal:  J Cell Biol       Date:  1993-08       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.